AMIX - Company ID 0001617867
The table below shows Autonomix Medical, Inc.'s income statement line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of revenue | - | - | - | - |
| Gross profit | - | - | - | - |
| R&D | $7.14M | $4.72M | $2.23M | $745.00K |
| SG&A | $9.89M | $6.86M | $5.25M | $1.25M |
| Operating income | -$17.03M | -$11.59M | -$12.03M | -$1.99M |
Autonomix Medical, Inc. reported annual revenue of $0.00 for fiscal year 2026. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$16.71M | -$11.41M | -$15.43M | -$1.99M |
| EPS (diluted) | - | - | - | - |